/VEXTF

VEXTF Stock - Vext Science, Inc.

Q: What is the analyst price target for VEXTF?

Analyst price target information is not currently available for VEXTF.

Q: What is VEXTF's market cap?

Market capitalization information is not currently available for VEXTF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.23+7.28%

+$0.02 (+7.28%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

100

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.26

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for VEXTF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.80

52W High$0.32

52W Low$0.07

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$36.00M	$34.81M	$35.41M	$37.24M	$25.19M
Gross Profit	$8.98M	$12.04M	$23.10M	$18.69M	$11.20M
Gross Margin	24.9%	34.6%	65.2%	50.2%	44.5%
Operating Income	$-11,180,000	$-1,802,112	$8.93M	$9.49M	$3.22M
Net Income	$-22,435,176	$4.40M	$10.92M	$4.99M	$2.13M
Net Margin	-62.3%	12.6%	30.8%	13.4%	8.4%
EPS	$-0.09	$0.03	$0.08	$0.04	$0.02

Company Overview

Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. The company is involved in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. It also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen and Pure Touch Botanicals brands. In addition, the company offers Vapen clear infused products, THC chocolate bars, THC syrup, THC snacks, candies, and gummies under Vapen Kitchens brand. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona .

Visit Website

Earnings History & Surprises

VEXTF

Beat Rate

36%

Last 11 quarters

Avg Surprise

-21.5%

EPS vs Estimate

Beats / Misses

4/5

2 met exactly

Latest EPS

$-0.01

Q4 2025

EPS Surprise History

Q4 23

No data

Q2 24

-27.6%

$-0.03vs$-0.02

Q3 24

-78.9%

$-0.02vs$-0.01

Q4 24

0.0%

$-0.01vs$-0.01

Q4 24

No data

Q2 25

0.0%

$-0.01vs$-0.01

Q3 25

-70.6%

$-0.01vs$-0.00

Q4 25

-51.6%

$-0.01vs$-0.01

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 19, 2026	—	—	—	—
Q4 2025	Nov 20, 2025	$-0.01	$-0.01	-51.6%	✗ MISS
Q3 2025	Aug 19, 2025	$-0.00	$-0.01	-70.6%	✗ MISS
Q2 2025	May 21, 2025	$-0.01	$-0.01	0.0%	= MET
Q4 2024	Dec 13, 2024	—	$-0.05	—	—
Q4 2024	Nov 21, 2024	$-0.01	$-0.01	0.0%	= MET
Q3 2024	Aug 20, 2024	$-0.01	$-0.02	-78.9%	✗ MISS
Q2 2024	May 29, 2024	$-0.02	$-0.03	-27.6%	✗ MISS
Q4 2023	Dec 30, 2023	—	$0.04	—	—
Q4 2023	Nov 28, 2023	$-0.00	$-0.01	-231.6%	✗ MISS
Q3 2023	Aug 23, 2023	$-0.01	$0.00	+148.5%	✓ BEAT
Q1 2023	Mar 22, 2023	—	$0.00	—	—
Q4 2022	Dec 31, 2022	—	$0.05	—	—
Q4 2022	Nov 17, 2022	—	$0.00	—	—
Q3 2022	Aug 24, 2022	—	$0.02	—	—
Q2 2022	Apr 20, 2022	$0.01	$0.01	+25.0%	✓ BEAT
Q4 2021	Dec 31, 2021	—	$0.01	—	—
Q4 2021	Nov 18, 2021	$0.01	$0.01	+25.0%	✓ BEAT
Q3 2021	Aug 24, 2021	$0.01	$0.01	+25.0%	✓ BEAT
Q2 2021	May 26, 2021	—	$0.01	—	—

Frequently Asked Questions about VEXTF

What is VEXTF's current stock price?

Vext Science, Inc. (VEXTF) is currently trading at $0.23 per share. The stock has moved +7.28% today.

What is the analyst price target for VEXTF?

No analyst price targets are currently available for this stock.

What sector is Vext Science, Inc. in?

Vext Science, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is VEXTF's market cap?

Vext Science, Inc. has a market capitalization of $0.06 billion, making it a small-cap company.

Does VEXTF pay dividends?

No, Vext Science, Inc. does not currently pay a dividend to shareholders.